PulmoBioMed Secures CE Marking for PBM-Hale Platform to Collect Saliva-Free Deep Lung Breath Samples

PulmoBioMed Ltd, a spinout company from Northumbria University, has achieved a significant milestone in respiratory medicine by securing CE marking for its PBM-Hale breath sampling platform. This approval marks the first regulatory recognition of a device capable of reliably collecting saliva-free exhaled breath condensates (EBC) directly from the deep lung. The achievement represents an advancement in medical technology, addressing challenges that have previously hindered accurate sampling of deep lung breath.

The PBM-Hale platform is designed to collect uncontaminated EBC samples, which are critical for precise analysis in respiratory research and diagnostics. Unlike traditional methods that often result in mixed samples containing saliva or upper airway contaminants, this device ensures the collection of pure condensates from deeper regions of the lungs. Peer-reviewed research has validated the reliability and effectiveness of this technology, further underscoring its potential impact on respiratory health studies and clinical applications.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 2, 2026

Author

GOAI